CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Operating activities
Net income (loss)	$ (3,859)	$ 1,992
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	8,600	8,572
Amortization of deferred financing costs charged to interest expense	857	880
Stock-based compensation expense	1,264	725
Deferred income taxes, net	(1,363)	1,530
Changes in operating assets and liabilities:
Accounts receivable	4,752	(1,864)
Other assets	1,958	(638)
Accounts payable and accrued liabilities	(6,801)	(7,927)
Accrued payroll	(4,972)	(402)
Other liabilities	(1,420)	97
Net cash provided by (used in) operating activities	(984)	2,965
Investing activities
Purchase of equipment and improvements	(39)	(1)
Net cash used in investing activities	(39)	(1)
Financing activities
Proceeds from revolving line of credit	112,030	117,850
Repayments of revolving line of credit	(109,408)	(116,008)
Repayments of debt obligations	(1,500)	(4,750)
Payments of deferred financing costs	0	(202)
Payments for taxes related to net share settlement of restricted stock units	(93)	0
Net cash provided by (used in) financing activities	1,029	(3,110)
Net change in cash	6	(146)
Cash - beginning of period	125	342
Cash - end of period	131	196
Supplemental disclosure of cash flow information
Cash paid during the period for interest	5,276	7,165
Cash paid during the period for income taxes	724	508
Common stock surrendered for the settlement of restricted stock units	93	0
Lease liability recognized to acquire a right-of-use asset	$ 0	$ 1,377